CLOs on the Move


 
LENSAR, Inc. is a global leader in next-generation femtosecond laser technology for refractive cataract surgery. The LENSAR Laser System offers cataract surgeons precision, accuracy, and efficiency while optimizing overall visual outcomes. LENSAR`s proprietary Augmented Reality technology -- reconstructed 3-D imaging, measurement, and guidance system -- offers quick and easy patient docking and provides high-resolution ocular images in a single scan. This technology facilitates enhanced procedure outcomes by allowing the physician to develop individualized treatment plans including precise laser delivery, and efficient lens fragmentation that can reduce, and potentially eliminate phaco energy. The LENSAR Laser System also offers the industry`s smallest ...
  • Number of Employees: 100-250
  • Annual Revenue: $50-100 Million
  • www.lensar.com
  • 2800 Discovery Drive
    Orlando, FL USA 32826
  • Phone: 888.536.7271

Executives

Name Title Contact Details

Similar Companies

International Medsurg Connection

International Medsurg Connection is a Schaumburg, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

JEOL

JEOL USA, Inc. is a wholly owned subsidiary of JEOL, Ltd. of Akishima, Japan.JEOL USA, Inc. was incorporated in the United States in 1962, and moved to present corporate offices at 11 Dearborn Road in Peabody, Massachusetts, in August 1979. The primary

Sonendo

Sonendo, Inc. is a privately held, venture-backed company developing innovative technologies to transform endodontic therapy. Sonendo`s Multisonic Ultracleaning technology addresses the challenges that currently exist in endodontic treatment, offering a solution to the problems that exist within traditional root canal therapy.

Imaging3

Imaging3 is a Burbank, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

VisCardia

VisCardia Inc is a privately held medical device company in Portland Oregon developing a novel chronic heart failure therapy. Our proprietary implantable system uses the patient’s own thoracic musculature to improve cardiac filling and output.